Sensitization to the alpha-gal epitope, as detected by anti-alpha-gal IgE positivity, is not synonymous with clinical allergy but indicates a higher risk of hypersensitivity reactions, necessitating careful monitoring at the beginning of treatment. The gene discussed is IGHE; the disease is Allergy.